Aggressive surgical resection after neoadjuvant chemoradiation therapy for locally advanced intrahepatic cholangiocarcinoma

被引:6
|
作者
Kato H. [1 ]
Tabata M. [1 ]
Kobayashi M. [1 ]
Ohsawa I. [1 ]
Kishiwada M. [1 ]
Mizuno S. [1 ]
Usui M. [1 ]
Sakurai H. [1 ]
Isaji S. [1 ]
机构
[1] Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate, School of Medicine, Tsu
关键词
Gemcitabine; Intrahepatic cholangiocarcinoma; Neoadjuvant chemoradiation therapy;
D O I
10.1007/s12328-009-0102-z
中图分类号
学科分类号
摘要
The poor prognosis of patients with intrahepatic cholangiocarcinoma (ICC) or hilar cholangiocarcinoma is well known. Herein, we described the first reported case of severe locally advanced ICC in which radical surgery was successfully achieved based on the marked effect of neoadjuvant chemoradiation therapy (NCRT) using gemcitabine. A 54-year-old man was admitted to our institution with obstructive jaundice. Abdominal computed tomography (CT) showed a large low-density mass in the caudate lobe, extensively involving the inferior vena cava and main portal vein. Moreover, nodal involvements of the hepatoduodenal ligament were detected concurrently. We therefore regarded this tumor as a severe locally advanced ICC and attempted to initiate combined treatment with gemcitabine (800 mg/m2 biweekly) and three-dimensional conformation radiation (45 Gy/25 days). After completion of NCRT, this patient underwent a left trisegmentectomy with combined resection of the portal vein and inferior vena cava. Postoperative microscopic findings surprisingly revealed that more than 90% of tumor cells had disappeared with extensive fibrosis, achieving tumor downstaging and tumor volume reduction which were related to the radical resection. In conclusion, ICC showed a favorable histological response to chemoradiation therapy using gemcitabine. Further studies are needed to conclusively assess the effect of NCRT on locally advanced ICC. © 2009 Springer.
引用
收藏
页码:351 / 354
页数:3
相关论文
共 50 条
  • [11] Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma
    Zhu, Hongxu
    Wang, Longrong
    Wang, Miao
    He, Xigan
    Xu, Weiqi
    Zhu, Weiping
    Zhao, Yiming
    Wang, Lu
    AMERICAN JOURNAL OF SURGERY, 2021, 222 (02) : 383 - 389
  • [12] Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
    Chen, Xing
    Du, Jinpeng
    Huang, Jiwei
    Zeng, Yong
    Yuan, Kefei
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (03) : 553 - 563
  • [13] Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review
    Grendar, Jan
    Grendarova, Petra
    Sinha, Richie
    Dixon, Elijah
    HPB, 2014, 16 (04) : 297 - 303
  • [14] Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Akira Nakashima
    Naru Kondo
    Ryutaro Sakabe
    Hiroki Ohge
    Taijiro Sueda
    Annals of Surgical Oncology, 2011, 18 : 651 - 658
  • [15] Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer
    Groot, Vincent P.
    Blair, Alex B.
    Gemenetzis, Georgios
    Ding, Ding
    Burkhart, Richard A.
    Yu, Jun
    Rinkes, Inne H. M. Borel
    Molenaar, I. Quintus
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    EJSO, 2019, 45 (09): : 1674 - 1683
  • [16] Phase I Trial of Neoadjuvant Chemoradiation with Gemcitabine and Surgical Resection for Cholangiocarcinoma Patients (NACRAC Study)
    Katayose, Yu
    Rikiyama, Toshiki
    Motoi, Fuyuhiko
    Yamamoto, Kuniharu
    Yoshida, Hiroshi
    Morikawa, Takanori
    Hayashi, Hiroki
    Kanno, Atsushi
    Hirota, Morihisa
    Satoh, Kennichi
    Ariga, Hisanori
    Suzuki, Masaki
    Ohyauchi, Motoki
    Kondo, Yutaka
    Ikeya, Shinichi
    Ogawa, Yoshihiro
    Shimosegawa, Tooru
    Egawa, Shinichi
    Unno, Michiaki
    HEPATO-GASTROENTEROLOGY, 2011, 58 (112) : 1866 - 1872
  • [17] Prognostic Factors After Surgical Resection for Intrahepatic, Hilar, and Distal Cholangiocarcinoma
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Kondo, Naru
    Sakabe, Ryutaro
    Ohge, Hiroki
    Sueda, Taijiro
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 651 - 658
  • [18] Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy
    Thuy B. Tran
    Chinmaya K. Bal
    Kurt Schaberg
    Teri A. Longacre
    Bhupinder S. Chatrath
    George A. Poultsides
    Digestive Diseases and Sciences, 2015, 60 : 3226 - 3229
  • [19] The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis
    Moustafa, M.
    Fasolo, E.
    Bassi, D.
    D'amico, F. E.
    Gringeri, E.
    Pawlik, Timothy M.
    Cillo, U.
    EJSO, 2020, 46 (04): : 632 - 637
  • [20] A case of giant intrahepatic cholangiocarcinoma with pathological complete remission after neoadjuvant therapy
    Leng, Xue
    Pu, Fang-fei
    Sun, Ming-qiang
    Zhang, Jian-yong
    ASIAN JOURNAL OF SURGERY, 2023, 46 (04) : 1832 - 1833